Author:
van Tellingen Olaf,Sonneveldt Anneloes L. C.,Beijnen Jos H.,Nooijen Willem J.,Kettenes-van den Bosch Jantien J.,Versluis Cornelis,Bult Auke
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference19 articles.
1. Bhushana Rao KSP, Collard MP, Trouet A (1985) Vinca-23-oyl amino acid derivatives as new anticancer agents (review). Anticancer Res 5: 379?386
2. Cersosimo RJ, Bromer R, Licciardello JTW, Ki Hong W (1983) Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid. Pharmacotherapy 3: 259?274
3. Cutts JH, Beer CT, Noble RL (1960) Biological properties of vincaleukoblastine, an alkaloid inVinca rosea Linn, with reference to its antitumour action. Cancer Res 20: 1023?1031
4. Depierre A, Lemarie E, Dabouis G, Garnier G, Jacoulet P, Dalphin JC (1991) A phase II study of navelbine (vinorelbine) in the treatment of non-small-cell lung cancer. Am J Clin Oncol 14: 115?119
5. Dyke RW, Nelson RL (1977) Phase I anti-cancer agents vindesine (desacetyl vinblastine amide sulfate). Cancer Treat Rev 4: 135?142
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献